Cited by 284Cardiovascular Health and Disease PreventionMenopause: Health Impacts and TreatmentsNitric Oxide and Endothelin Effects

Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy

Kalantaridou, Sophia N., Naka, Katerina K., Papanikolaou, Evangelos, Kazakos, Nicolaos, Kravariti, Maria, Calis, Karim A., Paraskevaidis, Evangelos A., Sideris, Demetrios A. +3 more·2004·The Journal of Clinical Endocrinology & Metabolism

Abstract

Normal menopause is associated with vascular endothelial dysfunction, an early stage of atherosclerosis. The effect of premature ovarian failure (or premature menopause) on endothelial function in young women is unknown. Endothelial function was assessed in 18 women with premature ovarian failure before and after 6 months of hormone therapy and was compared with the endothelial function of 20 age- and body mass index-matched premenopausal women. Brachial artery diameter was measured both during hyperemia (an index of endothelium-dependent vasodilation) and in response to glyceryl trinitrate (an index of endothelium-independent vaso-dilation). Flow-mediated dilation was significantly lower in women with premature ovarian failure at baseline (increase in brachial artery diameter during hyperemia by 3.06 +/- 4.33%) than in control women (increase by 8.84 +/- 2.15%; P < 0.0005). Glyceryl trinitrate-induced vasodilation did not differ between the groups. After hormone therapy for 6 months, flow-mediated dilation was improved in women with premature ovarian failure, increasing by more than 2-fold (7.41 +/- 3.86%; P < 0.005 compared with pretreatment) and reaching normal values (P not significant compared with control women). Glyceryl trinitrate-induced vasodilation did not change after treatment in women with premature ovarian failure. Young women with premature ovarian failure have significant vascular endothelial dysfunction. Early onset of endothelial dysfunction associated with sex steroid deficiency may contribute to the increased risk of cardiovascular disease and mortality in young women with premature ovarian failure. Hormone therapy restores endothelial function within 6 months of treatment.

Integrity signals

Registry

Crossref · 10.1210/jc.2004-0015

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endothelial dysfunction, which has been found in women with premature menopause and in those with adverse pregnancy outcomes, might trigger pregnancy complications and remain beyond these complications to predispose women to future cardiovascular disease.

    “Endothelial dysfunction, which has been found in women with premature menopause and in those with adverse pregnancy outcomes, might trigger pregnancy complications and remain beyond these complications to predispose women to future cardiovascular disease”

Cites

1 retracted

Flagged first, then by citations

1 of the 45 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kalantaridou, S. N., Naka, K. K., Papanikolaou, E., Kazakos, N., Kravariti, M., Calis, K. A., Paraskevaidis, E. A., Sideris, D. A., Tsatsoulis, A., Chrousos, G. P., & Michalis, L. K.
Affiliations
  • University of Ioannina (GR)
  • University Hospital of Ioannina (GR)
  • National Institutes of Health (US)
Corresponding author
Kalantaridou, Sophia N.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2004-08
Volume
89
Issue
8
Pages
3907-3913
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2104874274
Cited by
284
References
45
Citations by year
2026: 9 · 2025: 15 · 2024: 19 · 2023: 19 · 2022: 16 · 2021: 20 · 2020: 20 · 2019: 18 · 2018: 10 · 2017: 17 · 2016: 19 · 2015: 7 · 2014: 11 · 2013: 3 · 2012: 14
FWCI
5.01
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
Keywords
premature ovarian failure, endothelial dysfunction, hormone therapy, estrogen replacement therapy, flow-mediated dilation, endothelium-dependent vasodilation, nitroglycerin, premature menopause, sex hormone deficiency, cardiovascular risk, young women
MeSH terms
Adult, Brachial Artery, Constriction, Endothelium, Vascular, Female, Nitroglycerin, Hand, Humans, Hyperemia, Regional Blood Flow, Ultrasonography, Vasodilation, Vasodilator Agents, Cohort Studies, Estrogen Replacement Therapy, Primary Ovarian Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review